Boundless Bio, Inc. (BOLD)
2.32
-0.06
(-2.52%)
USD |
NASDAQ |
Nov 20, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
Boundless Bio Total Assets (Quarterly) : 63.59M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 63.59M |
| June 30, 2026 | 73.74M |
| March 31, 2026 | 140.97M |
| December 31, 2025 | 157.06M |
| September 30, 2025 | 168.72M |
| June 30, 2025 | 179.45M |
| March 31, 2025 | 191.24M |
| December 31, 2024 | 206.41M |
| Date | Value |
|---|---|
| September 30, 2024 | 175.09M |
| June 30, 2024 | 188.20M |
| March 31, 2024 | 117.08M |
| December 31, 2023 | 129.89M |
| September 30, 2023 | 143.74M |
| June 30, 2023 | 154.93M |
| March 31, 2023 | |
| December 31, 2022 | 76.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.872M |
| Shareholders Equity (Quarterly) | 61.72M |
| Current Ratio | 33.97 |
| Net Debt Paydown Yield | 17.07% |